Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study [View all]
But you can't get the cure due to corporate greed!
http://www.bloomberg.com/news/2013-04-27/gilead-bristol-hepatitis-c-drug-combo-cures-100-in-study.html?cmpid=yhoo
By Simeon Bennett - Apr 27, 2013 9:30 AM PT
A combination of hepatitis C drugs from Gilead Sciences Inc. (GILD) and Bristol-Myers Squibb Co. (BMY) cured 100 percent of patients in a trial, showing the success of a cocktail that doctors say they want yet may never be approved.
In a study among 41 patients of Gileads sofosbuvir combined with Bristols daclatasvir, with or without the generic antiviral ribavirin, 40 had undetectable virus in their blood 12 weeks after finishing six months of treatment, according to results presented today at a meeting in Amsterdam. The other patient didnt turn up to the last appointment and was later found to be virus-clear. Patients in both groups had failed prior treatment with either Vertex Pharmaceuticals Inc. (VRTX)s Incivek or Merck & Co. (MRK)s Victrelis.
The two companies have planned no further trials of the combo because Foster City, California-based Gilead is focusing on a cocktail that contains only its own drugs. The lack of a late-stage study, and the expense of the pills, will probably put the combination out of reach for doctors and patients, said Geoffrey Dusheiko, a professor of medicine at the Royal Free Hospital in London.